NFKB1 and colitis: However, some studies report that cPLA2α was upregulated and activated in the development of colitis in the DSS-induced mouse model and preventing cPLA2 upregulation by i.v. administration of antisense oligonucleotides against cPLA2 prevented NF-κB activation and expression of proinflammatory proteins [54].